2.975

0.85% 0.025

Maravai Lifesciences Holdings Inc (MRVI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MRVI? Forum Prognose

Schlusskurs vom Vortag:

$2.95

Offen:

$2.96

24-Stunden-Volumen:

1.36M

Relative Volume:

0.98

Marktkapitalisierung:

$436.22M

Einnahmen:

$185.74M

Nettoeinkommen (Verlust:

$-230.76M

KGV:

-3.284

EPS:

-0.9059

Netto-Cashflow:

$-70.72M

1W Leistung:

+3.30%

1M Leistung:

-16.20%

6M Leistung:

-4.65%

1J Leistung:

+53.35%

1-Tages-Spanne:

$2.94

$3.055

1-Wochen-Bereich:

$2.80

$3.055

52-Wochen-Spanne:

$1.665

$4.105

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Firmenname

Maravai Lifesciences Holdings Inc

Sektor

Healthcare (1117)

Branche

Biotechnology (624)

Telefon

(858) 546-0004

Adresse

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Mitarbeiter

435

Twitter

Nächster Verdiensttermin

2025-03-18

Neueste SEC-Einreichungen

MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, INSM

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
MRVI Maravai Lifesciences Holdings Inc	2.98	431.83M	185.74M	-230.76M	-70.72M	-0.9059
VRTX Vertex Pharmaceuticals Inc	433.89	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	763.12	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	747.85	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.40	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.62	35.01B	606.42M	-1.28B	-997.58M	-6.403

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-02-26	Herabstufung	Robert W. Baird	Outperform → Neutral
2024-12-19	Eingeleitet	Guggenheim	Neutral
2024-12-05	Herabstufung	Goldman	Neutral → Sell
2024-11-14	Eingeleitet	Wolfe Research	Peer Perform
2024-11-08	Herabstufung	William Blair	Outperform → Mkt Perform
2024-08-28	Eingeleitet	Wells Fargo	Overweight
2024-08-13	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-04-10	Eingeleitet	Craig Hallum	Buy
2023-12-12	Hochstufung	BofA Securities	Neutral → Buy
2023-08-08	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2023-05-23	Herabstufung	Credit Suisse	Outperform → Neutral
2023-05-09	Herabstufung	Goldman	Buy → Neutral
2023-01-05	Herabstufung	UBS	Buy → Neutral
2022-12-14	Eingeleitet	Deutsche Bank	Buy
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-11-03	Herabstufung	BofA Securities	Buy → Neutral
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2021-08-05	Fortgesetzt	Credit Suisse	Outperform
2020-12-16	Eingeleitet	KeyBanc Capital Markets	Overweight
2020-12-15	Eingeleitet	BofA Securities	Buy
2020-12-15	Eingeleitet	Credit Suisse	Outperform
2020-12-15	Eingeleitet	Goldman	Buy
2020-12-15	Eingeleitet	Jefferies	Buy
2020-12-15	Eingeleitet	Robert W. Baird	Outperform
2020-12-15	Eingeleitet	Stifel	Buy
2020-12-15	Eingeleitet	William Blair	Outperform
2020-12-14	Eingeleitet	UBS	Buy

Alle ansehen

Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten

02:42 AM

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Rating of "Hold" from Brokerages - MarketBeat

02:42 AM

Apr 05, 2026

Risk Recap: What is the dividend yield of Maravai LifeSciences Holdings IncShort Setup & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Prestige Consumer Healthcare (NYSE:PBH) and Maravai LifeSciences (NASDAQ:MRVI) Head-To-Head Survey - Defense World

Apr 03, 2026

Apr 02, 2026

Investors Purchase Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World

Apr 02, 2026

Apr 01, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect - ACCESS Newswire

Apr 01, 2026

Mar 31, 2026

Does Maravai LifeSciences Holdings Inc have strong fundamentals2026 Volume & Daily Momentum Trading Reports - baoquankhu1.vn

Mar 31, 2026

2026-03-31 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect | NDAQ:MRVI | Press Release - Stockhouse

Mar 31, 2026

MRVI Stockholders Have Opportunity to Lead Maravai LifeSciences H - The National Law Review

Mar 31, 2026

Profit Review: Can Maravai LifeSciences Holdings Inc lead its sector in growth2026 Investor Takeaways & Capital Protection Trading Alerts - baoquankhu1.vn

Mar 31, 2026

Mar 30, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Mar 30, 2026

Mar 29, 2026

How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value Targets - Yahoo Finance

Mar 29, 2026

Mar 28, 2026

Stop Loss: Is Maravai LifeSciences Holdings Inc in a bullish channel2026 Sector Moves & AI Based Trade Execution Alerts - baoquankhu1.vn

Mar 28, 2026

Mar 26, 2026

Recap Report: What is the dividend yield of Maravai LifeSciences Holdings IncGDP Growth & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn

Mar 26, 2026

Aug Gainers: How cyclical is CSWCs revenue stream2026 Analyst Calls & Capital Efficiency Focused Ideas - baoquankhu1.vn

Mar 26, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Mar 26, 2026

Stop Loss: What are Maravai LifeSciences Holdings Incs earnings expectationsEarnings Performance Report & Long-Term Capital Growth Strategies - baoquankhu1.vn

Mar 26, 2026

Maravai LifeSciences stock faces ongoing volatility amid restructuring efforts and biotech sector pr - AD HOC NEWS

Mar 26, 2026

Mar 25, 2026

Analysts’ Top Technology Picks: Blaize Holdings (BZAI), Zeta Global Holdings Corp (ZETA) - The Globe and Mail

Mar 25, 2026

Published on: 2026-03-25 14:27:07 - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026